Janux Therapeutics
JANX
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.45 | -0.36 | 0.09 | 20.00% |
| Revenue | 490K | 0.00 | -490K | -100.00% |
WhatIF - Earnings
EPS Beat Expectations by $0.09
Janux Therapeutics (JANX:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything